Resverlogix Corp. (RVXCF) - Latest Market Data

Track the most recent price, market cap, volume, and performance data for Resverlogix Corp. (RVXCF).

Download OTCGems on Google Play Download OTCGems on the App Store

Equity Overview

Price & Market Data

Price: $0.0314

Daily Change: $0.00 / 0.00%

Range: $0 - $0

Market Cap: $8,925,889

Volume: 0

Performance Metrics

1 Week: -5.85%

1 Month: 24.11%

3 Months: 5.90%

6 Months: -17.96%

1 Year: -9.77%

YTD: -8.19%

Company Details

Employees: 18

Sector: Health technology

Industry: Pharmaceuticals: major

Country: Canada

Details

Resverlogix Corp., a late-stage clinical biotechnology company, develops therapeutics for patients with chronic illnesses. The company's lead drug is apabetalone (RVX-208), a small molecule selective bromodomain and extra-terminal inhibitor for patients with cardiovascular disease, chronic kidney disease, type 2 diabetes mellitus, low high-density lipoprotein cholesterol, recent acute coronary syndrome, and post COVID-19 conditions. It has a partnership with Eversana Life Science Services, LLC to support the commercialization of apabetalone for COVID-19 in the United States and Canada; developing cardiovascular and pulmonary arterial hypertension indications; and Medison Pharma Ltd. The company is headquartered in Calgary, Canada.

Selected stocks

NIO Inc. (NIOIF)

AFFINITY BEVERAGE GROUP INC (ABVG)

Electric Last Mile Solutions Inc. (ELMSQ)